dc.contributor.author | Eriksen, Stein Sundstøl | |
dc.date.accessioned | 2020-05-05T07:03:47Z | |
dc.date.available | 2020-05-05T07:03:47Z | |
dc.date.created | 2020-04-30T13:51:39Z | |
dc.date.issued | 2020 | |
dc.identifier.uri | https://hdl.handle.net/11250/2653254 | |
dc.description.abstract | • The pandemic and lockdowns threaten the supply of medicines, especially from India • Poor countries relying on supplies of cheap Indian medicines are especially vulnerable • New medicines and vaccines are likely to be developed and patented by Western companies and will be expensive. • Norway should help fund the supply of medicines and promote reforms of patent rules to make medicines more affordable | |
dc.language.iso | eng | en_US |
dc.publisher | NUPI | en_US |
dc.relation.ispartof | NUPI Covid-19 Brief | |
dc.relation.ispartofseries | NUPI Covid-19 Brief;4/2020 | |
dc.rights | Navngivelse-Ikkekommersiell 4.0 Internasjonal | * |
dc.rights | Navngivelse-Ikkekommersiell 4.0 Internasjonal | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/deed.no | * |
dc.subject | Asia | |
dc.subject | India | |
dc.subject | Covid-19 | |
dc.subject | China | |
dc.title | China, India and the political economy of medical supplies | en_US |
dc.type | Research report | en_US |
dc.description.version | publishedVersion | |
dc.subject.nsi | VDP::Internasjonal politikk: 243 | |
dc.subject.nsi | VDP::International politics: 243 | |
dc.source.pagenumber | 5 | en_US |
dc.source.volume | 2020 | en_US |
dc.source.issue | 4 | en_US |
dc.identifier.cristin | 1808879 | |
dc.relation.project | Norges forskningsråd: 304516 | en_US |
cristin.ispublished | true | |
cristin.fulltext | original | |